Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 94 of the 97 references it cites were found in a registry or an index; 4 of the 134 sources its claims cite were checked for support.

Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart

Open access
Campi, Irene, Dell’Acqua, Marco, Stellaria Grassi, Elisa, Cristina Vigone, Maria, Persani, Luca · 2023 · European Thyroid Journal

Abstract

The clinical consequences of primary hypothyroidism include cardiovascular morbidity, increased mortality, and poor quality of life; therefore guidelines endorsed by several Scientific Societies recommend measuring circulating thyroid-stimulating hormone (TSH) in patients at risk. The assessment of serum TSH levels is also deemed to be the most robust and accurate biomarker during the management of replacement therapy in patients with a previous diagnosis of primary hypothyroidism. In line with a reflex TSH laboratory strategy, free thyroxine is measured only if the TSH falls outside specific cutoffs, in order to streamline investigations and save unjustified costs. This serum TSH-based approach to both diagnosis and monitoring has been widely accepted by several national and local health services; nevertheless, false-negative or -positive testing may occur, leading to inappropriate management or treatment. This review aims to describe several infrequent causes of increased circulating TSH, including analytical interferences, resistance to TSH, consumptive hypothyroidism, and refractoriness to levothyroxine replacement treatment. We propose a clinical flowchart to aid correct recognition of these various conditions, which represent important potential pitfalls in the diagnosis and treatment of primary hypothyroidism.

Overview

CoChat Summary

TL;DR

This narrative review describes infrequent causes of elevated TSH—assay interferences, critical illness/nonthyroidal illness, acute amiodarone, TSH resistance, refractoriness to levothyroxine, and consumptive hypothyroidism—and proposes a revised diagnostic flowchart. It emphasizes clinical assessment and targeted testing to avoid misdiagnosis and inappropriate treatment in primary hypothyroidism.

Key findings

  • Assay interferences are rare (<1% of samples) but can be harmful: in a review of 150 patients, >50% had mismanagement or adverse events; the probability of falsely raised TSH was estimated at 2.3–16.7% depending on hypothyroidism prevalence. Macro-TSH was found in 0.5–1.6% of samples referred for hypothyroidism and in 0.43% of neonates in one study.
  • Partial TSH resistance was estimated at 10–20% among young Italian patients with hyperthyrotropinemia without thyroid autoimmunity; heterozygous TSHR variants were estimated as high as 1:169 in a Hungarian congenital hypothyroidism cohort. Complete biallelic resistance causes severe congenital hypothyroidism with thyroid hypoplasia, moderate biallelic resistance causes high TSH with normal free T4, and mild monoallelic resistance causes slight TSH elevation with normal free T4.
  • Refractoriness to levothyroxine can result from poor compliance, malabsorption, nephrotic syndrome, drugs/foods, or resistance to exogenous thyroxine (RETH); in 18 RETH subjects, TSH normalized only with supraphysiological free T4 (>20 pmol/L) and thyrotoxic symptoms. In congenital hypothyroidism, 10–40% of neonates and children fail to normalize TSH despite adequate levothyroxine treatment.
  • Consumptive hypothyroidism is a rare paraneoplastic syndrome caused by tumors overexpressing type 3 deiodinase, often hepatic hemangiomas/endotheliomas in children; infantile hemangiomas affect 4–5% of Caucasian children, and treatment requires very high levothyroxine and/or liothyronine doses, with propranolol as first-line therapy for hemangioma control.

Methods

  • Narrative review of published literature, with no systematic search, meta-analysis, or primary data collection described; it includes summary tables, figures, and a proposed clinical flowchart.
  • Evidence is synthesized from cited studies and the authors’ institutional experience, including a described levothyroxine absorption test protocol: 1 mg levothyroxine with TSH and free T4 measured every 60 min up to 6 h, then at 2 and 7 days.
  • Main analysis is qualitative and clinical, aimed at differential diagnosis and management rather than statistical estimation.

Limitations

  • The paper states that a detailed discussion of the limitations of the reflex TSH screening approach is beyond its aims; it is a narrative review without systematic review methodology or primary data.
  • Some management recommendations rely on retrospective or cross-sectional studies and expert opinion—for example, the suggestion that levothyroxine may be avoided in mild TSH resistance is supported by retrospective cross-sectional studies.
  • The text notes there is no standardized protocol for the levothyroxine absorption test and no single method is 100% sensitive for detecting assay interference.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1530/etj-23-0012

Cites

94 of 94 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Revised diagnostic flowchart of high TSH levels. §Might be compatible with AITD in case of macro-TSH/HAMA associated with genuine hypothyroidism. #fT4 might be borderline high during amiodarone treatment. AD, autosomal dominant; AITD autoimmune thyroid diseases; L-T4, levothyroxine; MRI, magnetic resonance imaging; SHBG, sex hormone-binding globulin; SSA-LAR, long-acting somatostatin analog; Tg-Ab, anti-thyroglobulin antibodies; TPO-Ab, anti-thyroid peroxidase antibodies.
Figure 1 Revised diagnostic flowchart of high TSH levels. §Might be compatible with AITD in case of macro-TSH/HAMA associated with genuine hypothyroidism. #fT4 might be borderline high during amiodarone treatment. AD, autosomal dominant; AITD autoimmune thyroid diseases; L-T4, levothyroxine; MRI, magnetic resonance imaging; SHBG, sex hormone-binding globulin; SSA-LAR, long-acting somatostatin analog; Tg-Ab, anti-thyroglobulin antibodies; TPO-Ab, anti-thyroid peroxidase antibodies.CC BY · PubMed Central
Figure 2 TSH resistance: different degree of sensitivity to TSH actions. Panel A: normal TSH–TSHR binding. Panel B: complete resistance to TSH caused by a homozygous variant resulting in a complete loss of the function of the TSHR. This causes an overt hypothyroidism due to severe thyroid hypoplasia (congenital hypothyroidism). Panels C and D: partial resistance to TSH. In this case, the increased TSH levels can compensate the impaired function of the receptor and maintain normal fT4 serum levels. In particular, moderate resistance to TSH is caused by biallelic variants (panel C), one causing a complete functional impairment (red), while the other causing a milder impairment of the receptor’s functions (yellow). As a consequence, the size of the thyroid is slightly reduced. Panel D: mild resistance to TSH caused by monoallelic dominant-negative variant (red) able to interfere with TSHR dimers/oligomerization. The functions of the receptor are only slightly impaired and the thyroid gland is normal.
Figure 2 TSH resistance: different degree of sensitivity to TSH actions. Panel A: normal TSH–TSHR binding. Panel B: complete resistance to TSH caused by a homozygous variant resulting in a complete loss of the function of the TSHR. This causes an overt hypothyroidism due to severe thyroid hypoplasia (congenital hypothyroidism). Panels C and D: partial resistance to TSH. In this case, the increased TSH levels can compensate the impaired function of the receptor and maintain normal fT4 serum levels. In particular, moderate resistance to TSH is caused by biallelic variants (panel C), one causing a complete functional impairment (red), while the other causing a milder impairment of the receptor’s functions (yellow). As a consequence, the size of the thyroid is slightly reduced. Panel D: mild resistance to TSH caused by monoallelic dominant-negative variant (red) able to interfere with TSHR dimers/oligomerization. The functions of the receptor are only slightly impaired and the thyroid gland is normal.CC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 3 Not valid · 89 Not checked · 10 Own results and interpretations

51 more claims

Create a free account to see all 106 claims and to verify the 112 references still open.

See all claims — free account
  • It may state two separate claims as one. 48
  • Probably not a substantial claim. 8

Create a free account to see these claims.

Citations

Cites

Show all 97 references

Cited by

See all 13

Metadata

Authors
Campi, I., Dell’Acqua, M., Stellaria Grassi, E., Cristina Vigone, M., & Persani, L.
Affiliations
  • IRCCS Istituto Auxologico Italiano (IT)
  • University of Milan (IT)
  • Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy
  • Department of Paediatrics, IRCCS San Raffaele Hospital, Milan, Italy
Corresponding author
Campi, Irene
Venue
European Thyroid Journal
Published
2023-04-17
Volume
12
Issue
4
ISSN
  • 2235-0640 (ISSN-L)
  • 2235-0802
OpenAlex
W4366083112
Cited by
13
References
97
Citations by year
2026: 3 · 2025: 6 · 2024: 2 · 2023: 2
FWCI
0.47
Type
journal article
Language
en
Open access
Locations
  • European Thyroid Journal (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministero della Salute
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
Keywords
hyperthyrotropinemia, primary hypothyroidism, thyroid-stimulating hormone, TSH resistance, free thyroxine, analytical interference, differential diagnosis, diagnostic flowchart
MeSH terms
Diagnosis, Differential, Humans, Hypothyroidism, Quality of Life, Software Design, Thyrotropin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart. https://app.cochat.ai/papers/10.1530/etj-23-0012
The paper
Campi, I., Dell’Acqua, M., Stellaria Grassi, E., Cristina Vigone, M., & Persani, L. (2023). Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart. European Thyroid Journal. https://doi.org/10.1530/etj-23-0012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.